Drugplain

PETROLATUM .098 g/20g

iShanCare Hemorrhoid Cream · CREAM · Shenzhen Ishan Technology Co., Ltd

10 Recalls on Record
Plain English

PETROLATUM is a cream containing ishancare hemorrhoid cream at .098 g/20g, taken topical. Manufactured by Shenzhen Ishan Technology Co., Ltd.

Key Facts

Brand Name
PETROLATUM
Generic Name
iShanCare Hemorrhoid Cream
NDC Code (Product)
73076-129
Manufacturer
Shenzhen Ishan Technology Co., Ltd
Strength
.098 g/20g
Dosage Form
CREAM
Route
TOPICAL
Marketing Status
Marketing Start
12/02/2021

Recall History

10 Recalls on Record
Class II09/11/2024

Zhejiang Jingwei Pharmaceutical Co., Ltd.

Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.

OngoingVoluntary: Firm initiated
Class II04/09/2025

Apipharma

CGMP Deviations

OngoingVoluntary: Firm initiated
Class II07/02/2019

Altaire Pharmaceuticals, Inc.

Lack of Assurance of Sterility

CompletedVoluntary: Firm initiated
Class II01/30/2024

Brassica Pharma Pvt Ltd

Lack of Assurance of Sterility

OngoingVoluntary: Firm initiated
Class II08/27/2025

DermaRite Industries, LLC

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

OngoingVoluntary: Firm initiated
Class II08/24/2015

Allergan Sales, LLC

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

TerminatedVoluntary: Firm initiated
Class II12/07/2018

US Pharmaceuticals Inc.

GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample

TerminatedVoluntary: Firm initiated
Class II12/07/2018

US Pharmaceuticals Inc.

GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample

TerminatedVoluntary: Firm initiated
Class II09/16/2024

AbbVie Inc.

Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.

OngoingVoluntary: Firm initiated
Class II07/02/2019

Altaire Pharmaceuticals, Inc.

Lack of Assurance of Sterility

CompletedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

pyrexia69 reports
rash62 reports
pneumonia58 reports
diarrhoea54 reports
nausea46 reports
anaemia42 reports
febrile neutropenia42 reports
cellulitis39 reports
vomiting38 reports
sepsis35 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses ■ helps treat and prevent diaper rash ■ helps seal out wetness ■ temporarily protects minor ■ cuts ■ scrapes ■ burns ■ temporarily helps protect and relieve chapped and cracked skin or lips ■ helps prevent and protect chafed skin or minor skin irritations associated with diaper rash ■ with each diaper change, espicially at bedtime when exposure to wet diapers may be prolonged

Dosage & Administration

Directions ■ change wet and soiled diapers promptly ■ cleanse the diaper area and allow to dry ■ apply as needed

Warnings

Warnings For external use only

Frequently Asked Questions

What is PETROLATUM used for?

PETROLATUM contains iShanCare Hemorrhoid Cream. It is a cream taken topical. Consult your doctor for specific uses.

Is PETROLATUM a controlled substance?

PETROLATUM is not classified as a controlled substance by the DEA.

What is the generic name for PETROLATUM?

The generic name for PETROLATUM is iShanCare Hemorrhoid Cream. There are 1 other brand versions of iShanCare Hemorrhoid Cream.

What is the NDC code for PETROLATUM .098 g/20g?

The NDC (National Drug Code) for PETROLATUM .098 g/20g is 73076-129, listed by Shenzhen Ishan Technology Co., Ltd.

Product NDC

73076-129

Package NDC

73076-129-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)